CCI to investigate Mahyco Monsanto for abuse of dominance in charging royalties for

The Competition Commission of India (CCI) by way of its order dated June 9, 2016 directed the Director General (‘DG’)   to investigate Mahyco Monsanto Biotech (I) Limited, Monsanto Holdings Private Ltd., Monsanto Inc., U.S.A. and Maharashtra Hybrid Seeds Company Ltd. (collectively called as “Opposite parties”) pursuant to an information filed by Kaveri Seed Company ltd,…

COMPAT upholds CCI Order holding that IndiGo’s predatory recruitment of Air India’s trained pilots is not a competition issue but an employment issue-

COMPAT by its order dated April 29, 2016 has upheld the CCI order dated February 10, 2016 refusing to intervene in the matter of predatory recruitment of Air India’s trained pilot against InterGlobe Aviation Limited. (IndiGo) In its order, the CCI rejected Air India’s allegations against IndiGo for the violation of section 3(3) (b) and…

COMPAT sets-aside penalty imposed on All India Motor Transport Con-gress (AIMTC) for alleged increases of transport rates in collusion

COMPAT by its order dated April 18, 2016 has set-aside the order of CCI where AIMTC was penalized for allegedly exhorting truck transporters for increasing prices of transportation  by 15% following an increase of diesel price by INR 5/Ltr on 13 April 2012. In the present case, an information was filed by Indian Foundation of…

German Federal Cartel Office (FCO) prohibits the “best value” provisions of Booking.com

In December 2015 the Bundeskartellamt (FCO) prohibited booking.Com Deutschland GmbH from making use of its “best price” clauses and ordered the inn reserving portal to delete the clauses from its contracts and general terms and stipulations latest by 31 January 2016. Under the said provisos, inns were obliged to constantly offer Booking.com their most minimal…

COMPAT quashes penalty for individual liability imposed on a member of Executive Committee of a pharmaceutical distributors’ association

COMPAT, vide its order dated December 07, 2015 set-aside the penalty of INR 47,63,579/- imposed by CCI on Shri Swapan Kumar Karak (Director, Karak Pharmaceuticals) holding him accountable, as a member of the Executive Committee of Bengal Chemist and Druggist Association (BCDA), for the decision by BCDA to restrict discounts on medicines by the pharmaceutical…